Several studies have demonstrated that idebenone regulates NLRP3 inflammasome activity in rats with occlusion-induced ischemia and in mice with atherosclerosis mediated by apolipoprotein E deficiency (19, 53). Here, NLRP3 is linked to atherosclerosis.